Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor. - Institut Pasteur Access content directly
Journal Articles Molecular Pharmacology Year : 1998

Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.

Abstract

We report that preapplication of ivermectin, in the micromolar range, strongly enhances the subsequent acetylcholine-evoked current of the neuronal chick or human alpha7 nicotinic acetylcholine receptors reconstituted in Xenopus laevis oocytes and K-28 cells. This potentiation does not result from nonspecific Cl- currents. The concomitant increase in apparent affinity and cooperativity of the dose-response curve suggest that ivermectin acts as a positive allosteric effector. This interpretation is supported by the observation of an increase in efficiency of a partial agonist associated with the potentiation and by the differential effect of ivermectin on mutants within the M2 channel domain. Ivermectin effects reveal a novel allosteric site for pharmacological agents on neuronal alpha7 nicotinic acetylcholine receptors.
No file

Dates and versions

pasteur-01718414 , version 1 (27-02-2018)

Identifiers

Cite

Ryoko M. Krause, Bruno Buisson, Sonia Bertrand, Pierre-Jean Corringer, Jean-Luc Galzi, et al.. Ivermectin: a positive allosteric effector of the alpha7 neuronal nicotinic acetylcholine receptor.. Molecular Pharmacology, 1998, 53 (2), pp.283-94. ⟨10.1124/mol.53.2.283⟩. ⟨pasteur-01718414⟩
296 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More